XML 34 R21.htm IDEA: XBRL DOCUMENT v3.24.2.u1
WARRANTS
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
WARRANTS

13) WARRANTS

 

As discussed in Notes 5 and 6, respectively, the Company has previously issued the note warrants and the Q1-22 warrants. The Company also has warrants outstanding from a private placement completed in the fourth quarter of 2022 (the “Q4-22 warrants”).

 

As of June 30, 2024, the Company has the following warrants outstanding:

 

   Warrants
Outstanding
(in thousands)		   Exercise
Price		   Expiration
Date		  Classification
Q1-22 warrants   343   $38.20   September 9, 2027  Liability
Q4-22 warrants   4,370   $1.43   June 2, 2028  Equity
July 2023 note warrants   6,094   $1.43   July 14, 2028  Equity
December 2023 note warrant issued December 15, 2023   8,115   $1.43   December 15, 2028  Equity
December 2023 note warrant issued January 11, 2024   1,464   $1.43   January 11, 2029  Equity
    20,386            

 

As of June 30, 2024, the weighted average remaining contractual life of the warrants outstanding was 4.21 years and the weighted average exercise price was $2.05.